Filter
983
Text search:
viral
load
Featured
149
294
Language
Document type
475
234
133
54
32
23
20
4
4
2
Countries
67
49
32
29
29
26
24
22
22
22
22
15
15
14
13
12
12
11
11
11
10
10
10
9
9
9
9
8
8
7
7
7
7
6
6
6
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
487
82
28
23
22
16
14
Toolboxes
202
121
47
40
19
19
18
18
15
14
13
13
12
8
8
6
4
4
3
3
2
1
1
1
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
The current document provides the background, justification and objectives for the revision of WHO policy on LF-LAM. It provides details on the index test (AlereLAM) being assessed. It also describes the process of evidence retrieval, quality assessment and grading; formulation of the recommendation
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
Time for recognition of lay counsellors
Accessed November 2017
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
NHSP 2017- 2022 (Final draft)
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Rewiew Article
Hindawi Publishing Corporation, Tuberculosis Research and Treatment; Volume 2011, Article ID 712736, 6 pages, doi:10.1155/2011/712736
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
